Compare AKBA & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | NL |
|---|---|---|
| Founded | 2007 | 1891 |
| Country | United States | United States |
| Employees | N/A | 2263 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 283.1M |
| IPO Year | 2014 | 1994 |
| Metric | AKBA | NL |
|---|---|---|
| Price | $1.22 | $5.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 41.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.22% |
| EPS Growth | ★ 93.94 | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $158,285,000.00 |
| Revenue This Year | N/A | $9.32 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $64.33 |
| Revenue Growth | N/A | ★ 8.46 |
| 52 Week Low | $0.82 | $5.04 |
| 52 Week High | $3.81 | $8.60 |
| Indicator | AKBA | NL |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 44.47 |
| Support Level | $1.16 | $5.71 |
| Resistance Level | $1.52 | $5.87 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 7.59 | 33.03 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.